scholarly article | Q13442814 |
P2093 | author name string | Daniel J Conklin | |
J Christopher States | |||
Luping Guo | |||
Theresa S Chen | |||
Gavin E Arteel | |||
Juliane I Beier | |||
Heather L Miller | |||
Claudia von Montfort | |||
J Phillip Kaiser | |||
Marsha Liu | |||
Thomas Schlierf | |||
P2860 | cites work | Cancer risks from arsenic in drinking water | Q24554413 |
Exit from arsenite-induced mitotic arrest is p53 dependent | Q28391168 | ||
Steatohepatitis: a tale of two "hits"? | Q29547771 | ||
Hepatic damage caused by chronic arsenic toxicity in experimental animals | Q31423066 | ||
Heterogeneity and plasticity of hepatocyte lineage cells | Q32076111 | ||
Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites | Q33943279 | ||
Non-alcoholic fatty liver disease: lumen–liver interactions and possible role for probiotics | Q35114267 | ||
Identifying US populations for the study of health effects related to drinking water arsenic | Q35126077 | ||
Toxic metals and antioxidants: Part II. The role of antioxidants in arsenic and cadmium toxicity | Q35141191 | ||
Advances in alcoholic liver disease | Q35163801 | ||
Arsenic stimulates sinusoidal endothelial cell capillarization and vessel remodeling in mouse liver | Q35575155 | ||
STAT-3 overexpression and p21 up-regulation accompany impaired regeneration of fatty livers | Q35747457 | ||
Innate immunity in the liver | Q36036373 | ||
Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis | Q36050135 | ||
Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver | Q36081607 | ||
Cell cycle control in breast cancer cells | Q36305565 | ||
Apoptosis and necrosis in the liver: a tale of two deaths? | Q36382247 | ||
Metformin prevents alcohol-induced liver injury in the mouse: Critical role of plasminogen activator inhibitor-1 | Q37111703 | ||
Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology. | Q38296226 | ||
Oval cells compensate for damage and replicative senescence of mature hepatocytes in mice with fatty liver disease | Q38344957 | ||
p53 suppression of arsenite-induced mitotic catastrophe is mediated by p21CIP1/WAF1. | Q40292662 | ||
Arsenite delays progression through each cell cycle phase and induces apoptosis following G2/M arrest in U937 myeloid leukemia cells. | Q40444295 | ||
Measurement of homocyst(e)ine in the prediction of arteriosclerosis. | Q40456371 | ||
Sensitivity of myelomonocytic leukemia cells to arsenite-induced cell cycle disruption, apoptosis, and enhanced differentiation is dependent on the inter-relationship between arsenic concentration, duration of treatment, and cell cycle phase. | Q40846558 | ||
The determination of glutathione, cyst(e)ine, and other thiols and disulfides in biological samples using high-performance liquid chromatography with dual electrochemical detection | Q42993583 | ||
Chronic ethanol exposure potentiates lipopolysaccharide liver injury despite inhibiting Jun N-terminal kinase and caspase 3 activation | Q43867588 | ||
Cocoa extract protects against early alcohol-induced liver injury in the rat. | Q44137990 | ||
Functional importance of ICAM-1 in the mechanism of neutrophil-induced liver injury in bile duct-ligated mice | Q44620832 | ||
Estrogen signaling in livers of male mice with hepatocellular carcinoma induced by exposure to arsenic in utero | Q44802943 | ||
Chronic inorganic arsenic exposure induces hepatic global and individual gene hypomethylation: implications for arsenic hepatocarcinogenesis | Q44836543 | ||
Role of the renin-angiotensin system in hepatic ischemia reperfusion injury in rats | Q45045433 | ||
Life span profiles of glutathione and acetaminophen detoxification | Q45193638 | ||
The application of lipid-soluble stains in plastic-embedded sections | Q46144475 | ||
Implications of oxidative stress and hepatic cytokine (TNF-alpha and IL-6) response in the pathogenesis of hepatic collagenesis in chronic arsenic toxicity | Q46395238 | ||
Effect of chronic intake of arsenic-contaminated water on liver | Q46556903 | ||
Arsenic in drinking water and mortality from vascular disease: an ecologic analysis in 30 counties in the United States | Q46619067 | ||
Oval cell differentiation into hepatocytes in the acetylaminofluorene-treated regenerating rat liver. | Q51121407 | ||
Blood arsenic as a biomarker of arsenic exposure: results from a prospective study. | Q51157616 | ||
Enhanced urinary bladder and liver carcinogenesis in male CD1 mice exposed to transplacental inorganic arsenic and postnatal diethylstilbestrol or tamoxifen. | Q53596779 | ||
Hepatic manifestations in chronic arsenic toxicity | Q73107973 | ||
2-acetaminofluorene blocks cell cycle progression after hepatectomy by p21 induction and lack of cyclin E expression | Q73270737 | ||
S-adenosylmethionine and Pneumocystis carinii | Q73789341 | ||
Arsenite induces apoptosis in hepatocytes through an enhancement of the activation of Jun N-terminal kinase and p38 mitogen-activated protein kinase caused by partial hepatectomy | Q79783205 | ||
P433 | issue | 2 | |
P921 | main subject | lipopolysaccharide | Q421804 |
P304 | page(s) | 128-139 | |
P577 | publication date | 2007-08-31 | |
P1433 | published in | Toxicology and Applied Pharmacology | Q2446974 |
P1476 | title | Subhepatotoxic exposure to arsenic enhances lipopolysaccharide-induced liver injury in mice | |
P478 | volume | 226 |
Q42498074 | Acetaminophen increases the risk of arsenic-mediated development of hepatic damage in rats by enhancing redox-signaling mechanism |
Q37083454 | Altered Hepatic Transport by Fetal Arsenite Exposure in Diet-Induced Fatty Liver Disease. |
Q34375678 | Arsenic exposure through drinking water increases the risk of liver and cardiovascular diseases in the population of West Bengal, India |
Q35591935 | Arsenic toxicology: translating between experimental models and human pathology |
Q36423873 | Arsenic-induced Histological Alterations in Various Organs of Mice. |
Q35597576 | Chronic subhepatotoxic exposure to arsenic enhances hepatic injury caused by high fat diet in mice. |
Q36509012 | Delayed temporal increase of hepatic Hsp70 in ApoE knockout mice after prenatal arsenic exposure |
Q36567359 | Effects of Arsenite Exposure during Fetal Development on Energy Metabolism and Susceptibility to Diet-Induced Fatty Liver Disease in Male Mice |
Q28390580 | Exposure to moderate arsenic concentrations increases atherosclerosis in ApoE-/- mouse model |
Q33964023 | Exposure to multiple metals from groundwater-a global crisis: geology, climate change, health effects, testing, and mitigation |
Q39747691 | From the Cover: Arsenite Uncouples Mitochondrial Respiration and Induces a Warburg-like Effect in Caenorhabditis elegans |
Q38913773 | Hepatic transcriptomic responses in mice exposed to arsenic and different fat diet. |
Q90054424 | Highly Sensitive Endotoxin Assay Combining Peptide/Graphene Oxide and DNA-Modified Gold Nanoparticles |
Q92041795 | Inorganic arsenic exposure induces sex-disparate effects and exacerbates ischemia-reperfusion injury in the female heart |
Q29248099 | Metabolism Disrupting Chemicals and Metabolic Disorders |
Q35230745 | Novel mechanism of arenavirus-induced liver pathology |
Q35891242 | Oligofructose protects against arsenic-induced liver injury in a model of environment/obesity interaction |
Q41881135 | PI3K/Akt/JNK/c-Jun signaling pathway is a mediator for arsenite-induced cyclin D1 expression and cell growth in human bronchial epithelial cells |
Q28728378 | Prenatal arsenic exposure alters gene expression in the adult liver to a proinflammatory state contributing to accelerated atherosclerosis |
Q27687049 | Toxicant-associated steatohepatitis |
Q42955665 | Using iron precipitants to remove arsenic from water: is it safe? |
Q36935429 | Vinyl Chloride Metabolites Potentiate Inflammatory Liver Injury Caused by LPS in Mice. |
Search more.